Avidity Partners Management LP Werewolf Therapeutics, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.71 - $12.22 $1.8 Million - $5.93 Million	-485,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.48 - $17.65 $1.61 Million - $2.47 Million	-140,120 Reduced 22.41%	485,000 $5.78 Million
Q3 2021 Nov 15, 2021	SELL	$13.89 - $20.31 $349,264 - $510,694	-25,145 Reduced 3.87%	625,120 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$11.6 - $17.44 $7.54 Million - $11.3 Million	650,265 New	650,265 $11.3 Million

31.8M

700

500

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $52.3M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.